No Data
Earnings Preview: ALGS to Report Financial Results Post-market on November 06
$Aligos Therapeutics(ALGS.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Aligos Therapeutics(ALGS.US)$ to post revenue of USD333.3
Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024
Aligos Therapeutics' Promising Clinical Advancements and Buy Rating Driven by Strong Market Potential
Aligos Therapeutics up on FDA Clearance of IND Application for Its Hepatitis B Treatment
Express News | Aligos Therapeutics Inc - Phase 2 Filing for Alg-000184 Planned for Q1 2025
Express News | Aligos Therapeutics Announces U.S. FDA Clearance of Ind Application for Alg-000184
No Data
No Data